Rablip-20

Rablip-20 contains Rabeprazole Gastro-resistant Tablets I.P. 20 mg, a proton pump inhibitor (PPI) that suppresses gastric acid secretion by selectively blocking the H+/K+-ATPase enzyme at the secretory surface of the gastric parietal cell. Indications: • Gastroesophageal Reflux Disease (GERD) and erosive esophagitis • Duodenal and benign gastric ulcers • Zollinger-Ellison Syndrome • Maintenance therapy of healed GERD Directions: Swallow whole with a glass of water, preferably in the morning before breakfast. Do not crush or chew.